戻る Agenda
Session 3 Track 3: The Business of Science: A Strategic Approach to MSL Territory Planning, a Sobi Perspective
Session Chair(s)
Danielle Day, PhD
Senior Medical Director, Immunology, Rare Disease
Sobi, United States
The MSL territory plan can either be a strategic roadmap guiding the way to meaningful outcomes, or a check-the-box exercise that gets completed and never looked at again. Incorporating an entrepreneurial mindset when designing a territory plan can give the MSL an opportunity to run their geography as a small business, identifying unique opportunities for impact to patients, providers and payers that correspond to overall medical and company goals. This session will highlight what we can learn from medical and cross-functional partners who have been able to create effective territory plans that make it easy to demonstrate MSL impact and outcomes within their key external and internal stakeholders.
Learning Objective : At the conclusion of this session, participants should be able to:
- Discuss the purpose and potential impact of a strategic territory plan
- Create a territory plan that ties into overall company and Medical Affairs strategies
- Identify best practices to identify the unique opportunities within distinct territories
Speaker(s)
Speaker
Christina Wright, PharmD
Sobi Pharmaceutical, United States
National Director-MSLs Immunology
Speaker
Elaine Nadeau, PharmD
Sobi, United States
Senior Director, Head of US Field Medical Affairs & Medical Excellence
Speaker
Carol Vu
Sobi, United States
Thought Leader Liaison Director